Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.47 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | P4HB | P07237 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13269452 | 0.86 | OPRM1 (0.49) | OPRM1SMYD3KMT2AMEN1MAPT | |
| Hydrochloric Acid SCHEMBL26106636 | 0.85 | OPRM1 (0.48) | OPRM1SMYD3KMT2AMEN1MAPT | |
| SCHEMBL2025300 | 0.83 | OPRM1 (0.47) | OPRM1SMYD3KMT2AMEN1MAPT | |
| SCHEMBL8311121 | 0.83 | CYP4F2 (0.44) | OPRM1KMT2AMEN1MAPTATM | |
| SCHEMBL963382 | 0.82 | OPRM1 (0.51) | OPRM1SMYD3KMT2AMEN1MAPT | |
| SCHEMBL10285599 | 0.82 | OPRM1 (0.46) | OPRM1SMYD3KMT2AMEN1MAPT | |
| SCHEMBL743660 | 0.82 | MAPK1 (0.53) | OPRM1SMYD3KMT2AMEN1MAPT | |
| SCHEMBL13268736 | 0.81 | OPRM1 (0.50) | OPRM1SMYD3KMT2AMEN1MAPT | |
| Hydrochloric Acid SCHEMBL1282849 | 0.81 | OPRM1 (0.50) | OPRM1SMYD3KMT2AMEN1MAPT | |
| SCHEMBL379071 | 0.81 | OPRM1 (0.44) | OPRM1SMYD3KMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3401316-B1 | CHEMICAL PROCESS | GLAXO GROUP LTD (GB) | 2021-08-04 | — | — | EP | disclosed |
| CN-107163038-B | Chemical process | 葛兰素集团有限公司 | 2020-07-28 | — | — | CN | disclosed |
| EP-3401316-A1 | CHEMICAL PROCESS | GLAXO GROUP LIMITED (GB) | 2018-11-14 | — | — | EP | disclosed |
| EP-2885298-B1 | CHEMICAL PROCESS | GLAXO GROUP LTD (GB) | 2018-06-13 | — | — | EP | disclosed |
| US-9657011-B2 | Chemical process | GLAXO GROUP LIMITED (GB) | 2017-05-23 | — | — | US | disclosed |
| US-20160159786-A1 | CHEMICAL PROCESS | GLAXO GROUP LIMITED (GB) | 2016-06-09 | — | — | US | disclosed |
| US-9273001-B2 | Chemical process | GLAXO GROUP LIMITED (GB) | 2016-03-01 | — | — | US | disclosed |
| US-20150232423-A1 | CHEMICAL PROCESS | GLAXO GROUP LIMITED (GB) | 2015-08-20 | — | — | US | disclosed |
| EP-2885298-A1 | CHEMICAL PROCESS | Glaxo Group Limited (GB) | 2015-06-24 | — | — | EP | disclosed |
| WO-2014027045-A1 | CHEMICAL PROCESS | GLAXO GROUP LIMITED (GB) | 2014-02-20 | — | — | WO | disclosed |
| WO-2011029896-A1 | METHODS OF PREPARATION OF MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232423-A1 | CHEMICAL PROCESS | UMPS, UCK2, UGP2 | OPRM1 2311/4885SMYD3 3940/4885KMT2A 3979/4885 |
| US-20160159786-A1 | CHEMICAL PROCESS | UMPS, UCK2, UGP2 | OPRM1 2311/4885SMYD3 3940/4885KMT2A 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.